ACT on Alzheimer’s

The Alzheimer’s Prevention Initiative (API) Treatment Trial is a clinical trial in the largest kindred carrying the PS1 autosomal dominant mutation for early onset Alzheimer’s Disease and is sponsored by the Banner Institute, the pharmaceutical industry, and the NIH Asymptomatic subjects who are carriers for the PS1 mutation will be ... ................
................